To gain insight into the role of CCN1 in DR, we first enrolled participants including control participants without diabetes (Non-DM), diabetes participants without diabetic retinopathy (DM), and diabetes participants with retinopathy complication (DR) to examine the CCN1 protein level change in peripheral blood. The gene discussed is CCN1; the disease is diabetic retinopathy.